• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病中的胆汁酸清除率

Bile acid clearance in liver disease.

作者信息

Luey L K, Heaton K W

出版信息

Gut. 1979 Dec;20(12):1083-7. doi: 10.1136/gut.20.12.1083.

DOI:10.1136/gut.20.12.1083
PMID:527883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1412827/
Abstract

The disappearance of intravenously administered cholylglycine-14C was studied in the fasting and postprandial states in seven subjects with healthy livers and 10 patients with liver disease. In neither group was there any significant difference in the pattern of 14C disappearance. In another 10 patients with liver disease there was no significant change when a loading dose of cholylglycine was given orally two hours beforehand. Clearance of bile acids seems to be unimpaired in all except severe liver disease. The apparent deterioration in endogenous bile acid removal after meals may be due simply to the increased amount of bile acids which are in circulation and available for portosystemic shunting.

摘要

对7名肝脏健康的受试者和10名肝病患者在空腹和餐后状态下静脉注射甘氨胆酰 - 14C后的消失情况进行了研究。两组中14C消失模式均无显著差异。在另外10名肝病患者中,提前两小时口服甘氨胆酰负荷剂量后,也没有显著变化。除严重肝病外,胆汁酸清除似乎未受损害。餐后内源性胆汁酸清除的明显恶化可能仅仅是由于循环中胆汁酸量增加,可供门体分流。

相似文献

1
Bile acid clearance in liver disease.肝病中的胆汁酸清除率
Gut. 1979 Dec;20(12):1083-7. doi: 10.1136/gut.20.12.1083.
2
Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.正常人及肝病患者体内14C-甘氨胆酸清除的动力学
Gut. 1978 Dec;19(12):1110-5. doi: 10.1136/gut.19.12.1110.
3
Clinical value of bile salt tests in anicteric liver disease.胆汁盐检测在无黄疸型肝病中的临床价值
Gut. 1981 Feb;22(2):141-8. doi: 10.1136/gut.22.2.141.
4
Plasma disappearance of intravenously injected radiolabelled glycocholic acid in patients with liver disease.肝病患者静脉注射放射性标记甘氨胆酸后的血浆清除情况。
Aust N Z J Med. 1977 Apr;7(2):148-50. doi: 10.1111/j.1445-5994.1977.tb04682.x.
5
Clinical usefulness of serum cholylglycine determination in various liver diseases.血清甘氨胆酸测定在各种肝脏疾病中的临床应用价值。
Gastroenterol Jpn. 1982 Oct;17(5):447-52. doi: 10.1007/BF02774722.
6
[Determination of serum bile acids in hepatobiliary diseases. Clinical applicability].[肝胆疾病中血清胆汁酸的测定。临床应用]
Minerva Med. 1984 Jan 28;75(3-4):99-107.
7
Effects of a meal on plasma clearance of [14C]glycocholic acid and indocyanine green in man.进食对人体血浆中[14C]甘氨胆酸和吲哚菁绿清除率的影响。
Clin Sci (Lond). 1981 Sep;61(3):325-30. doi: 10.1042/cs0610325.
8
Determinants of fasting and postprandial serum bile acid levels in healthy man.健康男性空腹及餐后血清胆汁酸水平的决定因素
Am J Dig Dis. 1978 May;23(5):385-91. doi: 10.1007/BF01072919.
9
Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.患有和未患有慢性肝病的受试者口服和静脉注射胆酸后的血浆清除率。
Gut. 1980 Feb;21(2):123-7. doi: 10.1136/gut.21.2.123.
10
Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease.评估胆酰基['14C]甘氨酸的血浆消失情况作为肝细胞疾病的一项检测。
Gut. 1977 Sep;18(9):697-702. doi: 10.1136/gut.18.9.697.

引用本文的文献

1
Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection.总胆汁酸与胆固醇比值作为非胆汁淤积性慢性乙型肝炎病毒感染患者显著肝纤维化和肝硬化的新型无创标志物。
Medicine (Baltimore). 2020 Feb;99(8):e19248. doi: 10.1097/MD.0000000000019248.
2
Profiles of serum bile acids in liver diseases.肝脏疾病中的血清胆汁酸谱。
Korean J Intern Med. 1986 Jan;1(1):37-42. doi: 10.3904/kjim.1986.1.1.37.
3
Endogenous bile acid tolerance test for liver function.肝功能的内源性胆汁酸耐受性试验。
Dig Dis Sci. 1983 Feb;28(2):137-44. doi: 10.1007/BF01315143.

本文引用的文献

1
Bile salt secretion in cirrhosis of the liver.肝硬化时胆汁盐的分泌
Gut. 1970 Feb;11(2):126-33. doi: 10.1136/gut.11.2.126.
2
Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver.肝硬化患者胆结石发生率的尸检研究。
Gut. 1969 Sep;10(9):705-10. doi: 10.1136/gut.10.9.705.
3
Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis.Laënnec肝硬化患者胆石症发病率增加。发病机制的尸检评估。
Gastroenterology. 1972 Jul;63(1):112-21.
4
Postprandial serum bile acid for the detection of hepatobiliary disease.餐后血清胆汁酸用于肝胆疾病的检测。
JAMA. 1973 Jul 16;225(3):292-3.
5
Factors affecting plasma clearance of (14C) cholic acid in patients with cirrhosis.肝硬化患者中影响(14C)胆酸血浆清除率的因素。
Clin Sci Mol Med. 1973 Aug;45(2):147-61. doi: 10.1042/cs0450147.
6
Serum bile acid concentration after a test meal.试餐后血清胆汁酸浓度。
Scand J Gastroenterol. 1976;11(3):229-32.
7
Diagnositic value of serum bile acid estimations in liver disease.血清胆汁酸测定在肝脏疾病中的诊断价值。
J Clin Pathol. 1975 Jun;28(6):506-9. doi: 10.1136/jcp.28.6.506.
8
Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease.静脉胆汁酸耐量试验在肝病患者中的有效性和敏感性
N Engl J Med. 1975 Jun 5;292(23):1209-14. doi: 10.1056/NEJM197506052922303.
9
Serum bile acid concentrations in patients with liver disease.肝病患者的血清胆汁酸浓度。
Scand J Gastroenterol. 1976;11(5):537-43.
10
Evaluation of fluorimetrically estimated serum bile acid in liver disease.肝病中荧光法测定血清胆汁酸的评估。
Clin Chim Acta. 1977 Feb 15;75(1):81-90. doi: 10.1016/0009-8981(77)90502-2.